Patent ID: 7053112
Filing Date: 2006-05-30
Classification: C07D

Abstract:
1. A compound, or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of: 1-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-2,5-dioxo-4-phenyl-3-(phenylmethyl)-4-imidazolidineacetamide; 1-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-2,5-dioxo-4-phenyl-3-(phenylmethyl)-4-imidazolidineacetic acid; 1-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-2,5-dioxo-4-phenyl-3-(phenylmethyl)-4-imidazolidinepropanamide; 7-[[4-(4-aminophenyl)-4-methyl-2,5-dioxo-3-(phenylmethyl)-1-imidazolidinyl]methyl]-2-naphthalenecarboximidamide; 7-[[3-(4-aminophenyl)methyl)-4-methyl-2,5-dioxo-4-phenyl-1-imidazolidinyl]methyl]-2-naphthalenecarboximidamide; 7-[[4-(4-aminophenyl)-4-methyl-2,5-dioxo-3-(phenylmethyl)-1-imidazolidinyl]methyl]-2-naphthalenecarboximidamide; 4-[[3-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-5-methyl-2,4-dioxo-5-phenyl-1-imidazolidinyl]methyl]-benzamide; 3-[[3-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-5-methyl-2,4-dioxo-5-phenyl-1-imidazolidinyl]methyl]-benzamide; 7-[[3-[(3-aminophenyl)methyl]-4-methyl-2,5-dioxo-4-phenyl-1-imidazolidinyl]methyl]-2-naphthalenecarboximidamide; and 7-[[3-[[4-(aminoiminomethyl)phenyl]methyl]-4-methyl-2,5-dioxo-4-phenyl-1-imidazolidinyl]methyl]-2-naphthalene carboximidamide; as a single stereoisomer, a mixture of individual stereoisomers, or a racemic mixture.